Udai Banerji

Udai Banerji

Company: The Institute of Cancer Research, London

Job title: Professor & Deputy Director of The Drug Development Unit

Seminars:

Live Q&A Panel 4:15 pm

Ask Speakers Your Burning QuestionsRead more

day: Day Two

Clinical Combinations: Dual RAF-MEK Inhibitor & FAK for Treatment of KRAS Mutant Cancers With a Focus Low Grade Ovarian Cancer 3:35 pm

• Discuss preclinical rationale for the combination of a dual RAF-MEK and FAK inhibitor • Outline Phase I study including tolerability, pharmacokinetics an pharmacodynamics • Consider the clinical efficacy in low grade serious ovarian cancer and comparison with other existing therapiesRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.